A cancer-causing protein long thought to be resistant to medication could soon be the target of new drugs, thanks to the work ...

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.

Identifying a key protein's role could improve the common mental health medications and point to new treatments for inflammation-related diseases, a medicinal chemist says.